Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Common Equity (2016 - 2026)

Innoviva filings provide 17 years of Common Equity readings, the most recent being $1.2 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 69.69% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 69.69% increase, with the full-year FY2025 number at $1.2 billion, up 69.69% from a year prior.
  • Common Equity hit $1.2 billion in Q4 2025 for Innoviva, up from $1.0 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.2 billion in Q4 2025 to a low of $393.7 million in Q2 2021.
  • Median Common Equity over the past 5 years was $644.1 million (2022), compared with a mean of $656.3 million.
  • Biggest five-year swings in Common Equity: soared 71.65% in 2021 and later decreased 20.74% in 2022.
  • Innoviva's Common Equity stood at $525.9 million in 2021, then rose by 7.58% to $565.8 million in 2022, then grew by 19.29% to $675.0 million in 2023, then increased by 2.4% to $691.2 million in 2024, then skyrocketed by 69.69% to $1.2 billion in 2025.
  • The last three reported values for Common Equity were $1.2 billion (Q4 2025), $1.0 billion (Q3 2025), and $714.8 million (Q2 2025) per Business Quant data.